Outcome of renal-transplant (RT) patients switched from calcineurin inhibitors (CNIS) to sirolimus (SRL) for chronic allograft dysfuntion (CAD)

被引：0
|
作者：
Bumbea, V [1 ]
Ribes, D [1 ]
Kamar, N [1 ]
Esposito, L [1 ]
Nasou, G [1 ]
Modesto, A [1 ]
Durand, D [1 ]
Rostaing, L [1 ]
机构：
[1] CHU Rangueil, F-31054 Toulouse, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：V166 / V166
页数：1
相关论文
共 50 条
  • [1] Outcome of renal-transplant (RT) patients switched from calcineurin inhibitors (CNIs) to sirolimus (SRL) for chronic allograft dysfuntion (CAD).
    Bumbea, V
    Ribes, D
    Kamar, R
    Esposito, L
    Modesto, A
    Durand, D
    Rostaing, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 463 - 463
  • [2] Conversion from calcineurin inhibitors (CNIs) to sirolimus (SRL) immunosuppression is beneficial in liver transplant (LT) recipients with renal dysfunction (RD).
    Cejas, Nora
    Casciato, Paola
    Descalzi, Valeria
    Galdame, Omar
    Gadano, Adrian
    Imventarza, Oscar
    Villamil, Federico
    LIVER TRANSPLANTATION, 2007, 13 (06) : S113 - S113
  • [3] Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction
    Fischereder, M.
    Graeb, C.
    Krueger, B.
    Kammerl, M. C.
    Zuelke, C.
    Jauch, K. W.
    Kraemer, B. K.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1295 - 1297
  • [4] REDUCED INCIDENCE OF MALIGNANCY IN RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHIBITORS (CNIS) TO SIROLIMUS (SRL) COMPARED WITH THOSE WHO CONTINUED CNI THERAPY
    Pussell, B.
    Russ, G.
    Walker, R.
    Campbell, S.
    O'Connell, P.
    Kanellis, J.
    Eris, J.
    NEPHROLOGY, 2006, 11 : A24 - A24
  • [5] Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: A multicenter study
    Ruiz, JC
    Diekmann, F
    Campistol, JM
    Sanchez-Fructuoso, A
    Rivera, C
    Oliver, J
    Fernandez-Fresnedo, G
    Arias, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3833 - 3835
  • [6] Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients. A multicenter study
    Ruiz, JC
    Diekmann, F
    Campistol, JM
    Sanchez-Fructuoso, A
    Rivera, C
    Oliver, J
    Fernandez-Fresnedo, G
    Arias, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 519 - 519
  • [7] INCIDENCE OF DELAYED GRAFT FUNCTION (DGF) IN SIROLIMUS (SRL)-BASED REGIMENS COMPARED WITH CALCINEURIN INHIBITORS (CNIs) AND MYCOPHENOLATE MOFETIL (MMF) IN DE NOVO RENAL ALLOGRAFT RECIPIENTS
    Campistol, Josep M.
    Glyda, Maciej
    Gurkan, Alihan
    Flechner, Stuart M.
    Schulman, Seth
    Tai, Sandi See
    TRANSPLANT INTERNATIONAL, 2009, 22 : 121 - 121
  • [8] Proteinuria following switch from calcineurin inhibitors to sirolimus in renal transplant patients
    Colak, Turan
    Gorur, Sarp K.
    Karakayali, Hamdi
    Haberal, Mehmet
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 273 - 274
  • [9] Chronic allograft damage index (CADI) scoring at conversion from calcineurin inhibitors (CI) to Sirolimus predicts renal outcome in kidney transplant recipients.
    Sankaranarayanan, N
    Balarezo, F
    Alleman, K
    Brown, M
    Charpentier, K
    Lally, A
    Hull, D
    Ranga, KV
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 296 - 296
  • [10] Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus
    Bumbea, V
    Kamar, N
    Ribes, D
    Esposito, L
    Modesto, A
    Guitard, J
    Nasou, G
    Durand, D
    Rostaing, L
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (11) : 2517 - 2523
12345